On June 30, 2022, the U.S. Food and Drug Administration (FDA) issued a warning letter to the Kratom Exchange, addressing significant concerns regarding the marketing practices
On June 30, 2022, the U.S. Food and Drug Administration (FDA) issued a warning letter to Klarity Kratom, a manufacturer of kratom products, highlighting significant regulatory
This warning letter addresses regulatory violations identified at Herbsens Botanicals during an FDA inspection. The inspection revealed significant issues regarding the labeling and marketing practices of
On May 18, 2018, the U.S. Food and Drug Administration (FDA) issued a warning letter to Front Range Kratom regarding the sale and distribution of kratom
On September 4, 2018, the U.S. Food and Drug Administration (FDA) issued a warning letter to Chillin Mix Kratom, addressing significant safety concerns associated with the
The document is a warning letter issued by the FDA to Cali Botanicals, LLC, on June 11, 2019. It addresses the company’s marketing and sale of
The document is a warning letter issued by the FDA to Avalon Packaging on November 8, 2018, following an inspection of their facility from March 12
On June 30, 2022, the U.S. Food and Drug Administration (FDA) issued a warning letter to the Kratom Exchange, addressing significant concerns regarding the marketing practices
On June 30, 2022, the U.S. Food and Drug Administration (FDA) issued a warning letter to Klarity Kratom, a manufacturer of kratom products, highlighting significant regulatory
This warning letter addresses regulatory violations identified at Herbsens Botanicals during an FDA inspection. The inspection revealed significant issues regarding the labeling and marketing practices of
On May 18, 2018, the U.S. Food and Drug Administration (FDA) issued a warning letter to Front Range Kratom regarding the sale and distribution of kratom
On September 4, 2018, the U.S. Food and Drug Administration (FDA) issued a warning letter to Chillin Mix Kratom, addressing significant safety concerns associated with the
The document is a warning letter issued by the FDA to Cali Botanicals, LLC, on June 11, 2019. It addresses the company’s marketing and sale of
The document is a warning letter issued by the FDA to Avalon Packaging on November 8, 2018, following an inspection of their facility from March 12
The Kratom Research Institute was established to create a trusted hub for kratom-related information. We are a non-partisan organization focused solely on delivering facts, studies, and news, without promoting or opposing the use of kratom. Our goal is to offer a clear, objective view of the current state of kratom research, regulations, and public discourse.
We understand that kratom is a topic of debate, and that’s why we take a balanced approach—presenting information from all sides so you can make informed decisions based on credible sources.
